Tada, Keiichiro http://orcid.org/0000-0002-5395-986X
Kumamaru, Hiraku
Miyata, Hiroaki
Asaga, Sota
Iijima, Kotaro
Ogo, Etsuyo
Kadoya, Takayuki
Kubo, Makoto
Kojima, Yasuyuki
Tanakura, Kenta
Tamura, Kenji
Nagahashi, Masayuki
Niikura, Naoki
Hayashi, Naoki
Miyashita, Minoru
Yoshida, Masayuki
Ohno, Shinji
Imoto, Shigeru
Jinno, Hiromitsu
Article History
Received: 7 October 2022
Accepted: 9 December 2022
First Online: 22 December 2022
Declarations
:
: K. Tada, H. K., N. H., M. K., M. M., Y. K., N. N., and S. I. have received honorariums as speakers or consultant/advisory roles from Chugai Pharmaceutical Co. K. Tada, Y. K. and N. N. have received honorariums as speakers or consultant/advisory roles from AstraZeneca.Y.K. Have received honorariums as speakers or consultant/advisory roles from Eisai, Eli Lilly, Daiichi-Sankyo, Kyowa Hakko Kirin and Pfizer. N. N. have received honorariums as speakers or consultant/advisory roles from Novartis, Eisai, Eli Lilly, Daiichi-Sankyo, and Pfizer. H. K. Have received honorariums as speakers or consultant/advisory roles from Mitsubishi-Tanabe Pharma Corporation, and EP Croit Co., Ltd. S.I. have received honorariums as speakers or consultant/advisory roles from Eizai and Taiho. N.N. received research funding to Tokai University from Novartis, Chugai Pharmaceutical Co, Daiichi-Sankyo, Pfizer, Eisai, Eli Lilly and Mochida. HK and HM are affiliated with the Department of Health Quality Assessment at the University of Tokyo, a social collaboration department supported by the National Clinical Database, Johnson & Johnson K.K., Nipro Corporation, and Intuitive Surgical Sarl. S.O., S.I. and H.J. are board members of the Japanese Breast Cancer Society.
: This article does not contain any studies with animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.